高级检索
当前位置: 首页 > 详情页

The effects of vascular endothelial growth factor and microvessel density in the fibromyoma uteri

文献详情

资源类型:
WOS体系:
机构: [a]Department of Pathology, Matermal and Child Health Hospital of Kunming, Kunming 650031, China [b]Department of Gynecology, Matermal and Child Health Hospital of Kunming, Kunming 650031, China [c]Department of Pathology, The First Affiliated Hospital of Kunming Medical College, Kunming 650031, China
出处:
ISSN:

关键词: Fibromyoma uteri Microvessel density (MVD) Mifepristone Vascular endothelial growth factor (VEGF)

摘要:
Objective: To investigate vascular endothelial growth factor (VEGF) expression and microvessel density (MVD) on the fibromyoma uteri treated with mifepristone. Methods: VEGF expression and MVD were counted on 60 cases of the fibromyoma uteri by SP method, including 40 cases of mifepristone treated and 20 cases of untreated patients as controlled group. Results: VEGF positive expression rate and MVD in treated group were 37.5% and 9.90 ± 5.95, which were lower than those in controlled group (80% and 16.36 ± 2.07; P < 0.05). Meanwhile, in treated group, those in marked shrink in tumor size sub-group were lower than in not obvious sub-group (12.0% and 7.89 ± 4.36 vs. 80% and 11.29 ± 3.10; P < 0.05). Conclusion: VEGF and MVD expression decreases in the fibromyoma uteri after treatment with mifepristone, suggesting that mifepristone could inhibit angiogenesis and blood supply resulting in tumor shrink. © Springer-Verlag Berlin Heidelberg 2008.

语种:
第一作者:
第一作者机构: [a]Department of Pathology, Matermal and Child Health Hospital of Kunming, Kunming 650031, China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:53655 今日访问量:0 总访问量:1665 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)